nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—Nephrotic syndrome—Dapsone—leprosy	0.0332	0.132	CcSEcCtD
Auranofin—IKBKB—Endogenous TLR signaling—TLR1—leprosy	0.0301	0.0461	CbGpPWpGaD
Auranofin—IKBKB—p75NTR recruits signalling complexes—RIPK2—leprosy	0.025	0.0384	CbGpPWpGaD
Auranofin—IKBKB—Canonical NF-kappaB pathway—CYLD—leprosy	0.0246	0.0377	CbGpPWpGaD
Auranofin—IKBKB—p75NTR signals via NF-kB—RIPK2—leprosy	0.0212	0.0325	CbGpPWpGaD
Auranofin—IKBKB—NOD1/2 Signaling Pathway—CYLD—leprosy	0.0194	0.0297	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—IFNG—leprosy	0.0191	0.0294	CbGpPWpGaD
Auranofin—Proteinuria—Dapsone—leprosy	0.0183	0.0726	CcSEcCtD
Auranofin—Protein urine present—Dapsone—leprosy	0.018	0.0716	CcSEcCtD
Auranofin—PRDX5—eye—leprosy	0.018	0.187	CbGeAlD
Auranofin—IKBKB—Canonical NF-kappaB pathway—RIPK2—leprosy	0.0159	0.0243	CbGpPWpGaD
Auranofin—PRDX5—skin of body—leprosy	0.0157	0.162	CbGeAlD
Auranofin—IKBKB—Endogenous TLR signaling—TLR2—leprosy	0.0153	0.0235	CbGpPWpGaD
Auranofin—IKBKB—Canonical NF-kappaB pathway—NOD2—leprosy	0.0144	0.022	CbGpPWpGaD
Auranofin—IKBKB—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RIPK2—leprosy	0.0144	0.022	CbGpPWpGaD
Auranofin—IKBKB—TNF receptor signaling pathway —CYLD—leprosy	0.0141	0.0217	CbGpPWpGaD
Auranofin—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—leprosy	0.0132	0.0203	CbGpPWpGaD
Auranofin—IKBKB—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NOD2—leprosy	0.013	0.02	CbGpPWpGaD
Auranofin—IKBKB—NOD1/2 Signaling Pathway—RIPK2—leprosy	0.0125	0.0192	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—TNF—leprosy	0.0124	0.019	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—LTA—leprosy	0.0124	0.019	CbGpPWpGaD
Auranofin—PRDX5—tendon—leprosy	0.0119	0.124	CbGeAlD
Auranofin—Interstitial lung disease—Thalidomide—leprosy	0.0116	0.0461	CcSEcCtD
Auranofin—IKBKB—NOD1/2 Signaling Pathway—NOD2—leprosy	0.0113	0.0174	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-1 signaling—RIPK2—leprosy	0.0102	0.0156	CbGpPWpGaD
Auranofin—IKBKB—NOD pathway—RIPK2—leprosy	0.00998	0.0153	CbGpPWpGaD
Auranofin—IKBKB—Downstream TCR signaling—RIPK2—leprosy	0.00998	0.0153	CbGpPWpGaD
Auranofin—PRDX5—testis—leprosy	0.00987	0.102	CbGeAlD
Auranofin—PRDX5—nervous system—leprosy	0.00969	0.1	CbGeAlD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.00945	0.0145	CbGpPWpGaD
Auranofin—Proteinuria—Thalidomide—leprosy	0.00935	0.0372	CcSEcCtD
Auranofin—IKBKB—skin of body—leprosy	0.00928	0.0961	CbGeAlD
Auranofin—IKBKB—Interleukin-1 signaling—NOD2—leprosy	0.00923	0.0142	CbGpPWpGaD
Auranofin—Protein urine present—Thalidomide—leprosy	0.00922	0.0367	CcSEcCtD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—leprosy	0.00908	0.0139	CbGpPWpGaD
Auranofin—IKBKB—NOD pathway—NOD2—leprosy	0.00905	0.0139	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Dapsone—leprosy	0.0088	0.035	CcSEcCtD
Auranofin—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RIPK2—leprosy	0.00852	0.0131	CbGpPWpGaD
Auranofin—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—leprosy	0.00772	0.0118	CbGpPWpGaD
Auranofin—Aplastic anaemia—Thalidomide—leprosy	0.00771	0.0307	CcSEcCtD
Auranofin—IKBKB—TCR signaling—RIPK2—leprosy	0.00746	0.0114	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.00738	0.0113	CbGpPWpGaD
Auranofin—IKBKB—tendon—leprosy	0.00706	0.0732	CbGeAlD
Auranofin—IKBKB—p75(NTR)-mediated signaling—RIPK2—leprosy	0.00658	0.0101	CbGpPWpGaD
Auranofin—Dermatitis exfoliative—Thalidomide—leprosy	0.00632	0.0251	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—CD8A—leprosy	0.00616	0.00945	CbGpPWpGaD
Auranofin—IKBKB—Downstream TCR signaling—HLA-DRB1—leprosy	0.00616	0.00945	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—RIPK2—leprosy	0.00616	0.00945	CbGpPWpGaD
Auranofin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00596	0.0237	CcSEcCtD
Auranofin—IKBKB—testis—leprosy	0.00585	0.0606	CbGeAlD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.00583	0.00895	CbGpPWpGaD
Auranofin—IKBKB—nervous system—leprosy	0.00574	0.0595	CbGeAlD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—RIPK2—leprosy	0.00573	0.00879	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—leprosy	0.00558	0.00856	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—RIPK2—leprosy	0.00557	0.00855	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—leprosy	0.00552	0.00847	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—RIPK2—leprosy	0.00542	0.00831	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—RIPK2—leprosy	0.00532	0.00816	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—leprosy	0.00523	0.00802	CbGpPWpGaD
Auranofin—Dysphagia—Thalidomide—leprosy	0.00515	0.0205	CcSEcCtD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—RIPK2—leprosy	0.00514	0.00788	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—TLR2—leprosy	0.00514	0.00788	CbGpPWpGaD
Auranofin—Eosinophilia—Thalidomide—leprosy	0.0051	0.0203	CcSEcCtD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—NOD2—leprosy	0.00505	0.00775	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—leprosy	0.005	0.00768	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—RIPK2—leprosy	0.00493	0.00756	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—NOD2—leprosy	0.00491	0.00754	CbGpPWpGaD
Auranofin—Pancytopenia—Thalidomide—leprosy	0.00489	0.0195	CcSEcCtD
Auranofin—Neutropenia—Thalidomide—leprosy	0.00482	0.0192	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.00482	0.00739	CbGpPWpGaD
Auranofin—IKBKB—Type II diabetes mellitus—TNF—leprosy	0.00479	0.00735	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—NOD2—leprosy	0.00474	0.00727	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Dapsone—leprosy	0.00468	0.0186	CcSEcCtD
Auranofin—Weight decreased—Thalidomide—leprosy	0.00466	0.0185	CcSEcCtD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—NOD2—leprosy	0.00466	0.00715	CbGpPWpGaD
Auranofin—IKBKB—EBV LMP1 signaling—TNF—leprosy	0.00462	0.00709	CbGpPWpGaD
Auranofin—IKBKB—Canonical NF-kappaB pathway—TNF—leprosy	0.00462	0.00709	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling—HLA-DRB1—leprosy	0.0046	0.00706	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—RIPK2—leprosy	0.0046	0.00706	CbGpPWpGaD
Auranofin—Abdominal pain—Dapsone—leprosy	0.00453	0.018	CcSEcCtD
Auranofin—Neuropathy peripheral—Thalidomide—leprosy	0.0045	0.0179	CcSEcCtD
Auranofin—Stomatitis—Thalidomide—leprosy	0.00448	0.0178	CcSEcCtD
Auranofin—IKBKB—MyD88-independent cascade—NOD2—leprosy	0.00447	0.00686	CbGpPWpGaD
Auranofin—Conjunctivitis—Thalidomide—leprosy	0.00447	0.0178	CcSEcCtD
Auranofin—IKBKB—Activated TLR4 signalling—RIPK2—leprosy	0.00444	0.0068	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—TLR2—leprosy	0.00444	0.0068	CbGpPWpGaD
Auranofin—Haematuria—Thalidomide—leprosy	0.00438	0.0174	CcSEcCtD
Auranofin—IKBKB—Downstream TCR signaling—CD4—leprosy	0.00435	0.00667	CbGpPWpGaD
Auranofin—Agranulocytosis—Thalidomide—leprosy	0.00429	0.0171	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—HLA-DRB1—leprosy	0.00421	0.00646	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—RIPK2—leprosy	0.00417	0.0064	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TLR2—leprosy	0.00417	0.0064	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—NOD2—leprosy	0.00417	0.0064	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—CD8A—leprosy	0.00403	0.00619	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—NOD2—leprosy	0.00402	0.00617	CbGpPWpGaD
Auranofin—Visual impairment—Thalidomide—leprosy	0.00398	0.0158	CcSEcCtD
Auranofin—Eye disorder—Thalidomide—leprosy	0.00386	0.0153	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—NOD2—leprosy	0.00378	0.0058	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.00376	0.00577	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—RIPK2—leprosy	0.00372	0.0057	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—TLR2—leprosy	0.00372	0.0057	CbGpPWpGaD
Auranofin—Alopecia—Thalidomide—leprosy	0.00365	0.0145	CcSEcCtD
Auranofin—Vomiting—Dapsone—leprosy	0.00364	0.0145	CcSEcCtD
Auranofin—Flatulence—Thalidomide—leprosy	0.00354	0.0141	CcSEcCtD
Auranofin—Dysgeusia—Thalidomide—leprosy	0.00352	0.014	CcSEcCtD
Auranofin—ALB—testis—leprosy	0.00341	0.0354	CbGeAlD
Auranofin—Nausea—Dapsone—leprosy	0.0034	0.0135	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—NOD2—leprosy	0.00337	0.00517	CbGpPWpGaD
Auranofin—Anaemia—Thalidomide—leprosy	0.00332	0.0132	CcSEcCtD
Auranofin—Angioedema—Thalidomide—leprosy	0.00328	0.013	CcSEcCtD
Auranofin—IKBKB—TCR signaling—CD4—leprosy	0.00325	0.00498	CbGpPWpGaD
Auranofin—Leukopenia—Thalidomide—leprosy	0.00321	0.0128	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—leprosy	0.00297	0.00455	CbGpPWpGaD
Auranofin—Thrombocytopenia—Thalidomide—leprosy	0.00287	0.0114	CcSEcCtD
Auranofin—IKBKB—TWEAK Signaling Pathway—TNF—leprosy	0.00286	0.00438	CbGpPWpGaD
Auranofin—Anorexia—Thalidomide—leprosy	0.00279	0.0111	CcSEcCtD
Auranofin—IKBKB—TNF receptor signaling pathway —TNF—leprosy	0.00266	0.00407	CbGpPWpGaD
Auranofin—Dyspepsia—Thalidomide—leprosy	0.00258	0.0103	CcSEcCtD
Auranofin—Decreased appetite—Thalidomide—leprosy	0.00255	0.0101	CcSEcCtD
Auranofin—Constipation—Thalidomide—leprosy	0.00251	0.00996	CcSEcCtD
Auranofin—Gastrointestinal pain—Thalidomide—leprosy	0.0024	0.00953	CcSEcCtD
Auranofin—Urticaria—Thalidomide—leprosy	0.00233	0.00926	CcSEcCtD
Auranofin—Abdominal pain—Thalidomide—leprosy	0.00232	0.00921	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—CD4—leprosy	0.00232	0.00355	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TNF—leprosy	0.0023	0.00353	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—RIPK2—leprosy	0.00215	0.00329	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RIPK2—leprosy	0.00211	0.00324	CbGpPWpGaD
Auranofin—Pruritus—Thalidomide—leprosy	0.00207	0.00824	CcSEcCtD
Auranofin—Diarrhoea—Thalidomide—leprosy	0.00201	0.00797	CcSEcCtD
Auranofin—ALB—Vitamin B12 Metabolism—IFNG—leprosy	0.002	0.00306	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NOD2—leprosy	0.00195	0.00299	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CYLD—leprosy	0.00187	0.00287	CbGpPWpGaD
Auranofin—Vomiting—Thalidomide—leprosy	0.00186	0.00741	CcSEcCtD
Auranofin—Rash—Thalidomide—leprosy	0.00185	0.00735	CcSEcCtD
Auranofin—Dermatitis—Thalidomide—leprosy	0.00185	0.00734	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—IL2—leprosy	0.00184	0.00283	CbGpPWpGaD
Auranofin—Nausea—Thalidomide—leprosy	0.00174	0.00692	CcSEcCtD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.00165	0.00253	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—leprosy	0.00164	0.00252	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TNF—leprosy	0.00164	0.00252	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IFNG—leprosy	0.00162	0.00249	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PARK2—leprosy	0.00159	0.00243	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—TNF—leprosy	0.00153	0.00234	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL2—leprosy	0.00144	0.00221	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.0014	0.00215	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.00132	0.00203	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—leprosy	0.00129	0.00198	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IFNG—leprosy	0.00129	0.00198	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TLR2—leprosy	0.0012	0.00185	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—RIPK2—leprosy	0.0012	0.00185	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RIPK2—leprosy	0.00116	0.00177	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.0011	0.00168	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NOD2—leprosy	0.00109	0.00167	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CYLD—leprosy	0.00109	0.00167	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—leprosy	0.00105	0.00161	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IFNG—leprosy	0.000967	0.00148	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PARK2—leprosy	0.000962	0.00148	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—leprosy	0.000942	0.00145	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD40LG—leprosy	0.000886	0.00136	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—leprosy	0.000876	0.00134	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—leprosy	0.00086	0.00132	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000839	0.00129	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—leprosy	0.000835	0.00128	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DRB1—leprosy	0.000713	0.00109	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RIPK2—leprosy	0.000701	0.00108	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR2—leprosy	0.000701	0.00108	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NOD2—leprosy	0.000636	0.000975	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—leprosy	0.000549	0.000842	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD40LG—leprosy	0.000537	0.000824	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—leprosy	0.000531	0.000815	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD4—leprosy	0.000524	0.000804	CbGpPWpGaD
Auranofin—ALB—Metabolism—SDHD—leprosy	0.000523	0.000802	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—leprosy	0.000503	0.000772	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RIPK2—leprosy	0.000453	0.000695	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DRB1—leprosy	0.000433	0.000664	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNG—leprosy	0.000316	0.000485	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—leprosy	0.000305	0.000468	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—leprosy	0.000283	0.000434	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—leprosy	0.000281	0.000431	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—leprosy	0.000182	0.000278	CbGpPWpGaD
